Rita Karachun

Rita Karachun

Chief Executive Officer at IMMUNE DESIGN CORP

Net worth: 42 000 $ as of 30/06/2026

62 year
Health Technology
Consumer Services
Communications

Profile

Rita A. Karachun is currently Chief Executive Officer & Director at Immune Design Corp.
since 2019, President & Director at Harrisvaccines LLC, Director at Jersey Battered Women's Service, Inc. since 2016, and Independent Director at Coherus Oncology, Inc. starting in 2024.
Former roles include Chief Executive Officer & Director at Prometheus Biosciences, Inc., Director at Organon & Co., President & Director at Acceleron Pharma, Inc., ArQule, Inc., GlycoFi, Inc., and Imago BioSciences, Inc., Senior Vice President-Finance & Global Controller at Merck & Co., Inc. from 2014 to 2023, President at Inspire Pharmaceuticals, Inc., and Chief Accountant & Assistant Controller at AT&T Corp.
from 1996 to 2006.
Education includes undergraduate studies at Fairleigh Dickinson University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
05/06/2026 30,000 ( 0.02% ) 42 000 $ 30/06/2026

Rita Karachun active positions

CompaniesPositionStart
IMMUNE DESIGN CORP Chief Executive Officer -
COHERUS ONCOLOGY, INC. Director/Board Member 31/05/2024
President -
Director/Board Member 01/07/2016

Former positions of Rita Karachun

CompaniesPositionEnd
MERCK & CO., INC. Comptroller/Controller/Auditor 04/12/2023
ORGANON & CO. Director/Board Member 02/06/2021
Comptroller/Controller/Auditor 01/01/2006
PROMETHEUS BIOSCIENCES, INC. Chief Executive Officer -
IMAGO BIOSCIENCES, INC. President -
See the detail of Rita Karachun's experience

Training of Rita Karachun

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

77

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Communications

Health Services

Health Technology

Health Technology

Health Technology

Health Technology